Abstract
The emergence of Omicron as the fifth variant of concern within the SARS-CoV-2 pandemic in late 2021, characterized by its rapid transmission and distinct spike gene mutations, underscored the pressing need for cost-effective and efficient methods to detect viral variants, especially given their evolving nature. This study sought to address this need by assessing the effectiveness of two SARS-CoV-2 variant classification platforms based on RT-PCR and mass spectrometry. The primary aim was to differentiate between Delta, Omicron BA.1, and Omicron BA.2 variants using 618 COVID-19-positive samples collected from Bangkok patients between November 2011 and March 2022. The analysis revealed that both BA.1 and BA.2 variants exhibited significantly higher transmission rates, up to 2-3 times, when compared to the Delta variant. This research presents a cost-efficient approach to virus surveillance, enabling a quantitative evaluation of variant-specific public health implications, crucial for informing and adapting public health strategies.
Funding Information
  • King Chulalongkorn Memorial Hospital (65-C7-030, U01AI151797, N35A640452, N35A640037, PO202704176)
  • National Institute of Allergy and Infectious Diseases of the National Institute of Health (65-C7-030, U01AI151797, N35A640452, N35A640037, PO202704176)
  • National Research Council of Thailand (65-C7-030, U01AI151797, N35A640452, N35A640037, PO202704176)
  • World Health Organization (65-C7-030, U01AI151797, N35A640452, N35A640037, PO202704176)

This publication has 22 references indexed in Scilit: